The group’s principle activity is to provide musculoskeletal research service to pharmaceutical, biotechnology, and orthopaedic industries. The group’s products include OSSForce(TM)Implant Controller, and OSSPlate(TM). The group’s services include implant evaluations, osteoporosis treatment efficacy testing, and preclinical study design services. The group operates from United States.
